Trial intelligence / Profile preview

Sevoflurane Effect on Cerebral Vasoreactivity and Systemic Arteries

NCT02054143Phase 4Completed

Sponsor
University of Debrecen
Start
Nov 2012
Primary completion
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of sevoflurane, sponsored by University of Debrecen. Primary endpoint: Mean Blood Flow Velocity in the Middle Cerebral Artery at 25 months. Started Nov 2012; status: completed.

02

Drugs

sevoflurane

Beyond the preview

Go deeper on NCT02054143.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02054143.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call